#IR_Category

We announced that the payment procedure for 20,639 shares of new shares with transfer restrictions as part of the stock-based reward plan has been completed on July 21, 2026. The issue price was 1,085 yen, totaling 22,393,315 yen. The recipients are five directors and four executive officers with assigned roles.

Sumitomo Pharma announced that it has decided not to proceed with the planned third-party allotment of shares at the Board of Directors meeting on April 8, 2026, and that the 7,695,600 shares scheduled for issuance will not be issued.